Advertisement
Advertisement

AXDX

AXDX logo

Accelerate Diagnostics, Inc.

0.65
USD
-0.04
-6.33%
Apr 04, 15:53 UTC -4
Closed
exchange

After-Market

0.65

0.00
0.00%

Accelerate Diagnostics, Inc. Profile

About

Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado.

Info & Links

CEO

Jack Phillips

Headquarters

3950 South Country Club Road, Suite 470
Tucson, AZ 85714, UNITED STATES

Industry

Medical Instruments

Sector

Medical

Website

https://acceleratediagnostics.com

Auditor

Ernst & Young LLP

Share holders

33

Employees

134

Accelerate Diagnostics, Inc. Statistics

Valuation Measures

Market Capitalization2

16.30M

Enterprise Value

54.78M

Enterprise Value/EBITDA(ttm)

-2.00

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

2.33

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

23.03%

Operating Margin(ttm)

-471.83%

Profit Margin(ttm)

-426.95%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-353.37%

Return on Assets(ttm)

-191.66%

Income Statement

Revenue(ttm)

11.91M

Revenue Per Share(ttm)

0.48

Gross Profit(ttm)

2.89M

EBITDA(ttm)3

-27.43M

Net Income Available to Common(ttm)

-53.45M

Diluted EPS(ttm)

-2.86

Share Statistics

Beta (5Y Monthly)

0.61

52-Week Change

-28.10%

S&P 500 52-Week Change

-2.50%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

25.04M

Dividend Yield

0.00%

Float4

14.13M

% Held by Insiders

43.60%

% Held by Institutions

17.14%

Balance Sheet

Total Cash(mrq)

20.91M

Total Cash Per Share(mrq)

0.84

Total Debt(mrq)

58.17M

Total Debt/Equity(mrq)

-113.26%

Current Ratio(mrq)

0.71%

Quick Ratio(mrq)

1.34%

Book Value Per Share(mrq)

-2.23

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.04

Free Cash Flow(ytd)

-24.70M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement